Growth Metrics

Resmed (RMD) Other Non-Current Liabilities (2016 - 2025)

Resmed (RMD) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $138.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 1179.09% year-over-year to $138.5 million, compared with a TTM value of $138.5 million through Dec 2025, up 1179.09%, and an annual FY2025 reading of $141.5 million, up 234.9% over the prior year.
  • Other Non-Current Liabilities was $138.5 million for Q4 2025 at Resmed, roughly flat from $138.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $141.5 million in Q2 2025 and bottomed at $5.1 million in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $54.0 million, with a median of $49.8 million recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities crashed 90.51% in 2022, then surged 1179.09% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $53.2 million in 2021, then decreased by 4.96% to $50.6 million in 2022, then surged by 44.05% to $72.9 million in 2023, then crashed by 85.14% to $10.8 million in 2024, then soared by 1179.09% to $138.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for RMD at $138.5 million in Q4 2025, $138.2 million in Q3 2025, and $141.5 million in Q2 2025.